MedPath

SOTYKTU

SOTYKTU

Approved
DIN Number

02533030

Drug Class

Human

Market Date

Feb 14, 2023

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02533030
AIG Number0164321001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AF07 DEUCRAVACITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification84:06.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEUCRAVACITINIBActive
Strength: 6 MG
Monograph: DEUCRAVACITINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.